# anti-HBs 10.4: does it count as protection? What a borderline anti-HBs value means, why vaccine immunity differs from recovery, and when to repeat the test. - URL: https://openhbv.com/articles/anti-hbs-10-4-does-it-count-as-protection?locale=en - Language: en - Translation key: anti-hbs-10-threshold-meaning - Review status: source_backed - Last reviewed: 2026-11-02 - Audience: Patients and families - Region: Global - Tags: Serology, Monitoring, Functional cure ## What anti-HBs means anti-HBs is the antibody against hepatitis B surface antigen. It can come from a completed hepatitis B vaccine series, or from clearing HBsAg after infection and developing protective antibody. Both are called "anti-HBs positive", but they mean different things and lead to different next steps. Never read anti-HBs alone. Read it with HBsAg and anti-HBc: HBsAg positive means surface antigen is still present; anti-HBc positive usually means current or past infection. Only together can a clinician tell vaccine immunity, recovery from past infection, and changes during chronic infection apart. ## What the number 10.4 means Many laboratories use 10 mIU/mL as the reference threshold for protective antibody, so 10.4 sits just above the line. Reagents, units, and cut-offs differ between laboratories, and the closer a value is to the threshold, the more it needs the full report and earlier results to interpret. If HBsAg is negative, anti-HBc is negative, and you completed the vaccine series, 10.4 can usually be read as a vaccine response. That does not mean other risks can be ignored, and it does not automatically mean you need a booster. ## Vaccine immunity versus recovery from infection First, after vaccination: completed series, HBsAg negative, anti-HBc negative, anti-HBs above the line. Routine boosters are generally not needed, but health care workers, dialysis patients, people on immune-suppressing treatment, and partners of people with hepatitis B can ask a clinician whether retesting or a booster is appropriate. Second, after infection: HBsAg was positive, and during follow-up HBsAg falls or clears while anti-HBs appears. That is the direction of functional cure, but it needs confirmation that HBsAg stays negative and HBV DNA is undetectable, and a clinician must judge it. One result is not a reason to stop treatment or declare a cure. ## Why borderline values need a repeat test A value sitting at 10 mIU/mL can shift with reagents, lot numbers, blood collection, and storage. The safer approach is to repeat the test at the same laboratory with the same method, together with older results, rather than comparing single numbers across hospitals. If anti-HBs turns from negative to around 10 while HBsAg is still positive, that antibody does not mean the same thing as vaccine immunity. A clinician needs to interpret it with HBV DNA, ALT, quantitative HBsAg, and current treatment. ## If HBsAg is falling Falling quantitative HBsAg, undetectable HBV DNA, and newly appearing anti-HBs is good news, but follow-up must continue: HBsAg, HBV DNA, ALT, and fibrosis assessment should stay on the clinician's schedule so the change is confirmed as sustained. People taking antivirals should not stop because anti-HBs appeared. Stopping needs an assessment of cirrhosis, HBsAg status, duration of viral suppression, and follow-up capacity, with close monitoring afterwards. ## Questions to ask at your next visit 1. Is my anti-HBs of 10.4 from vaccination, or from recovery during infection? 2. Are my HBsAg and anti-HBc negative or positive? 3. Is this value close enough to the threshold that it should be repeated with the same method? 4. Am I in a group that needs a booster? 5. If HBsAg is falling, which tests are next and how often? 6. If I take antivirals, can we discuss stopping now, and what would need to be met? ## Action checklist Keep HBsAg, anti-HBs, anti-HBc, HBV DNA, and ALT results in one folder. Confirm borderline anti-HBs values at the same laboratory. Do not stop antivirals because one anti-HBs result crossed the line. Ask whether you need a booster if you are in a high-risk group. Seek care promptly for jaundice, dark urine, marked fatigue, or abdominal swelling. ## References - [CDC Hepatitis B Testing and Diagnosis](https://openhbv.com/sources/cdc-hepatitis-b-testing-and-diagnosis.md?locale=en) — Centers for Disease Control and Prevention - Original: https://www.cdc.gov/hepatitis-b/hcp/diagnosis-testing/index.html - Section: Serology interpretation - Note: CDC testing guidance explains anti-HBs together with HBsAg and anti-HBc; one antibody value is not enough to judge immunity. - Quote: - Accessed: 2026-11-02 - [CDC Hepatitis B Vaccine Administration](https://openhbv.com/sources/cdc-hepatitis-b-vaccine-administration.md?locale=en) — Centers for Disease Control and Prevention - Original: https://www.cdc.gov/hepatitis-b/hcp/vaccine-administration/index.html - Section: Vaccine response and protective antibody - Note: CDC vaccine guidance uses a protective anti-HBs level as the marker of vaccine response and lists groups who may need retesting or boosters. - Quote: - Accessed: 2026-11-02 - [WHO 2024 Chronic Hepatitis B Guidelines](https://openhbv.com/sources/who-2024-chronic-hepatitis-b-guidelines.md?locale=en) — World Health Organization - Original: https://www.who.int/publications/i/item/9789240090903 - Section: Functional cure and HBsAg clearance - Note: WHO 2024 guidance treats HBsAg clearance as the ideal endpoint and emphasizes long-term treatment and follow-up for most people. - Quote: - Accessed: 2026-11-02 - [Hepatitis B Foundation Patient Resources](https://openhbv.com/sources/hepatitis-b-foundation-patient-resources.md?locale=en) — Hepatitis B Foundation - Original: https://www.hepb.org/ - Section: Patient education on antibody results - Note: Hepatitis B Foundation patient resources explain that antibody results must be read with vaccine and infection history. - Quote: - Accessed: 2026-11-02 - [AASLD Hepatitis B Guidance](https://openhbv.com/sources/aasld-hepatitis-b-guidance.md?locale=en) — American Association for the Study of Liver Diseases - Original: https://www.aasld.org/ - Section: Stopping treatment - Note: AASLD guidance requires cirrhosis status, viral suppression, and follow-up capacity to be assessed before stopping treatment. - Quote: - Accessed: 2026-11-02 This tool is for health education only and does not provide a personal diagnosis or treatment advice. Please consult a qualified doctor for individual medical decisions.